Oxford Asset Management’s Elevance Health ELV Stock Holding History

Oxford Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$225K	Buy	+583	New	+$216K	0.11%	290
2025 Q4	–	Sell	-4,138	Closed	-$1.34M	–	574
2025 Q3	$1.34M	Buy	+4,138	New	+$1.29M	0.44%	47
2025 Q1	–	Sell	-1,776	Closed	-$655K	–	539
2024 Q4	$655K	Buy	1,776 +238	+15%	+$99.6K	0.29%	101
2024 Q3	$800K	Buy	+1,538	New	+$822K	0.67%	25
2019 Q2	–	Sell	-1,949	Closed	-$559K	–	1778
2019 Q1	$559K	Buy	+1,949	New	+$564K	0.01%	1168
2018 Q1	–	Sell	-8,930	Closed	-$2.03M	–	1687
2017 Q4	$2.03M	Sell	8,930 -13,596	-60%	-$2.9M	0.04%	567
2017 Q3	$4.27M	Buy	22,526 +18,456	+453%	+$3.51M	0.08%	271
2017 Q2	$766K	Buy	+4,070	New	+$731K	0.02%	975

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Oxford Asset Management's ELV Position: Q2 2026 in Review

Oxford Asset Management opened a new position in Elevance Health (ELV) in Q2 2026: 583 shares worth $225K. The stake represents 0.11% of the portfolio and ranks #290 among its holdings. This is a return to the name: Oxford Asset Management previously reported a position in ELV as recently as Q3 2025.

Oxford Asset Management first reported a position in ELV in Q2 2017 and has held it in 8 quarters since. The position peaked at $4.27M in Q3 2017. 1,608 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Oxford Asset Management held 583 shares of Elevance Health worth $225K as of Q2 2026.
Elevance Health was a new Oxford Asset Management position in Q2 2026.
Elevance Health made up 0.11% of Oxford Asset Management's portfolio in Q2 2026, its #290 holding.
Oxford Asset Management first reported a position in Elevance Health in Q2 2017 and has held it in 8 quarters since.
Oxford Asset Management's Elevance Health position peaked at $4.27M in Q3 2017.
1,608 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.